panel’s

Pfizer gets FDA panel’s backing in RSV vaccine race

By Khushi Mandowara and Mariam ESunny (Reuters) – A panel of outside advisers to the U.S. health regulator on Tuesday recommended Pfizer Inc’s respiratory syncytial virus (RSV) vaccine, bringing it closer to…
February 28, 2023